Light-responsive charge-reversal nanovector for high-efficiency in vivo CRISPR/Cas9 gene editing with controllable location and time
- 18 June 2020
- journal article
- research article
- Published by Tsinghua University Press in Nano Research
- Vol. 13 (9) , 2399-2406
Abstract
Controllably and efficaciously localized CRISPR/Cas9 plasmids transfection plays an essential role in genetic editing associated with various key human diseases. We employed near-infrared (NIR) light-responsive CRISPR/Cas9 plasmids delivery via a charge-reversal nanovector to achieve highly efficient and site-specific gene editing. The nanovector with abundant positive charges was fabricated on the basis of an ultraviolet-sensitive conjugated polyelectrolyte coated on an upconversion nanomaterial (UCNP-UVP-P), which can convert into negative charges upon 980 nm light irradiation. Using the as-prepared nanovector, we demonstrated the plasmids could be efficiently transfected into tumor cells (∼ 63% ± 4%) in a time-controlled manner, and that functional CRISPR/Cas9 proteins could be successfully expressed in a selected NIR-irradiated region. Particularly, this strategy was successfully applied to the delivery of CRISPR/Cas9 gene to tumor cells in vivo, inducing high efficiency editing of the target gene PLK-1 under photoirradiation. Therefore, this precisely controlled gene regulation strategy has the potential to serve as a new paradigm for gene engineering in complex biological systems.Keywords
This publication has 56 references indexed in Scilit:
- CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral DeliveryChemical Reviews, 2017
- Applications of CRISPR technologies in research and beyondNature Biotechnology, 2016
- Cas9 gRNA engineering for genome editing, activation and repressionNature Methods, 2015
- Applications of the CRISPR–Cas9 system in cancer biologyNature Reviews Cancer, 2015
- In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9Nature Biotechnology, 2014
- CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer ModelingCell, 2014
- Prevention of muscular dystrophy in mice by CRISPR/Cas9–mediated editing of germline DNAScience, 2014
- CRISPR-mediated direct mutation of cancer genes in the mouse liverNature, 2014
- Development and Applications of CRISPR-Cas9 for Genome EngineeringCell, 2014
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012